It was found that multiple signaling pathways (MAPK, ErbB, VEGF, mTOR, Wnt and PI3K-Akt) are closely correlated with CML pathogenesis and progression (Table S1). The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.